Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Dec. 24, 2015

View Archived Issues

Tagged for Market: Luminex gears up for flu season with Nxtag RPP assay launch in U.S.

Prosthesis Kept Ticking: Third Carmat heart patient dies as firm pushes for 25 more in 2016

Holiday Notice

Grants: Transgenomic gets STTR grant for ICP

Daily M&A: Intuitive to buy out Luna's shape-sensing technology

Agreements/contracts: Cerus to supply RI blood centers with Intercept

Product briefs

Product briefs: Allosource approved for acellular human matrix

MDD's Orthopedics Extra

Combined Sales Force Seeks Greater Penetration: Cryolife enters heart valve market via $130 million On-X acquisition

Regulatory: FTC applies truth-in-advertising standards to digital media

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 14, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...